Active Stocks : Texas Instruments Inc. (NASDAQ:TXN), Banco Bradesco S.A. (NYSE:BBD), Syneron Medical Ltd. (NASDAQ:ELOS), Support.com (NASDAQ:SPRT), Alliance Fiber Optic Products (NASDAQ:AFOP)
Texas Instruments (TI) (NASDAQ: TXN) announced it has shipped more than 22 billion units of copper wire bonding technology from its internal assembly sites and is now in production for major high reliability applications including automotive and industrial. The majority of TI’s existing analog and CMOS silicon technology nodes have been qualified with copper, and all new TI technologies and packages are being developed with … Continue reading Active Stocks : Texas Instruments Inc. (NASDAQ:TXN), Banco Bradesco S.A. (NYSE:BBD), Syneron Medical Ltd. (NASDAQ:ELOS), Support.com (NASDAQ:SPRT), Alliance Fiber Optic Products (NASDAQ:AFOP)
Today’s Hot List : The Dow Chemical Company (NYSE:DOW), The Walt Disney Company (NYSE:DIS), HopFed Bancorp Inc. (NASDAQ:HFBC), Rudolph Technologies (NYSE:RTEC), GCI
The Dow Chemical Company (NYSE:DOW) won U.S. approval for its Enlist Duo weed killer, clearing the way for sales of corn and soybeans genetically engineered to tolerate the herbicide. The Dow Chemical Company (NYSE:DOW) belongs to Basic Materials sector. Its net profit margin is 5.90% and weekly performance is -11.82%. On last trading day company shares ended up $44.09. The Dow Chemical Company (NYSE:DOW) distance … Continue reading Today’s Hot List : The Dow Chemical Company (NYSE:DOW), The Walt Disney Company (NYSE:DIS), HopFed Bancorp Inc. (NASDAQ:HFBC), Rudolph Technologies (NYSE:RTEC), GCI
Active Watch List : Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Alibaba Group Holding Ltd (NYSE:BABA), Hewlett-Packard Company (NYSE:HPQ), SunEdison, Inc. (NYSE:SUNE), Navient Corporation (NASDAQ:NAVI)
Inovio Pharmaceuticals (NYSE:INO) CFO Peter Kies purchased 3,960 shares of the stock in a transaction dated Thursday, October 9th. The stock was purchased at an average price of $10.10 per share, with a total value of $39,996.00. Following the acquisition, the chief financial officer now directly owns 21,388 shares in the company, valued at approximately $216,019. T Inovio Pharmaceuticals, Inc. (NASDAQ:INO) belongs to Healthcare sector. … Continue reading Active Watch List : Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Alibaba Group Holding Ltd (NYSE:BABA), Hewlett-Packard Company (NYSE:HPQ), SunEdison, Inc. (NYSE:SUNE), Navient Corporation (NASDAQ:NAVI)
Market Movers : Web.com Group, Inc. (NASDAQ:WWWW), Wells Fargo & Company (NYSE:WFC), Martha Stewart Living Omnimedia Inc. (NYSE:MSO), Union Bankshares (NASDAQ:UNB), HHC
Web.com Group, Inc. (NASDAQ:WWWW) posted third-quarter 2014 adjusted earnings of 63 cents per share that topped the Zacks Consensus Estimate of 59 cents per share while rising 8.6% year over year. Web.com Group, Inc. (NASDAQ:WWWW) belongs to Technology sector. Its net profit margin is -1.80% and weekly performance is -4.61%. On last trading day company shares ended up $18.64. Web.com Group, Inc. (NASDAQ:WWWW) distance from … Continue reading Market Movers : Web.com Group, Inc. (NASDAQ:WWWW), Wells Fargo & Company (NYSE:WFC), Martha Stewart Living Omnimedia Inc. (NYSE:MSO), Union Bankshares (NASDAQ:UNB), HHC
60 Years Later, This Underappreciated Technology Continues to Ensure Safer Financial Transactions
With the speed and convenience that advancements in technology have afforded us, its no wonder why we have seen our lives “digitized” at a rapid pace. Everything from shopping to socializing can be done from the comfort of our own home. Although as this shift has occurred, combined with more and more of our personal information being stored on servers around the world, cyber security … Continue reading 60 Years Later, This Underappreciated Technology Continues to Ensure Safer Financial Transactions
Biotech Stock News: Gilead Inc Gets Another Major Boost
Good news flowed in at Gilead Sciences (GILD) with the FDA approving the company’s Harvoni for treating patients affected with chronic hepatitis C virus (HCV) genotype 1 infection. Harvoni is a once-daily combination treatment of Gilead’s highly successful HCV drug Sovaldi (sofosbuvir 400 mg) and ledipasvir (a NS5A inhibitor 90 mg). Following the FDA approval, Harvoni becomes the first single tablet regimen to treat HCV … Continue reading Biotech Stock News: Gilead Inc Gets Another Major Boost
